NCT01870895View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)

PHASE3CompletedINTERVENTIONAL
Enrollment

577

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Diarrhea-predominant Irritable Bowel Syndrome
Interventions
DRUG

YM060

oral

DRUG

Placebo

oral

Trial Locations (4)

Unknown

Hokkaido

Kansai

Kantou

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01870895 - A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) | Biotech Hunter | Biotech Hunter